JP2008535909A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008535909A5 JP2008535909A5 JP2008506051A JP2008506051A JP2008535909A5 JP 2008535909 A5 JP2008535909 A5 JP 2008535909A5 JP 2008506051 A JP2008506051 A JP 2008506051A JP 2008506051 A JP2008506051 A JP 2008506051A JP 2008535909 A5 JP2008535909 A5 JP 2008535909A5
- Authority
- JP
- Japan
- Prior art keywords
- ccr2
- molecule
- mcp
- amino acid
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67147605P | 2005-04-15 | 2005-04-15 | |
| PCT/IL2006/000454 WO2006109301A2 (en) | 2005-04-15 | 2006-04-10 | Molecules and methods of using same for treating mcp-1/ccr2 associated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008535909A JP2008535909A (ja) | 2008-09-04 |
| JP2008535909A5 true JP2008535909A5 (https=) | 2009-04-02 |
Family
ID=36688002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008506051A Pending JP2008535909A (ja) | 2005-04-15 | 2006-04-10 | Ｍｃｐ−１／ｃｃｒ２関連疾患を治療するための分子およびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8388962B2 (https=) |
| EP (1) | EP1871798B1 (https=) |
| JP (1) | JP2008535909A (https=) |
| CN (1) | CN101160323A (https=) |
| AT (1) | ATE445644T1 (https=) |
| AU (1) | AU2006233927A1 (https=) |
| CA (1) | CA2597789A1 (https=) |
| DE (1) | DE602006009786D1 (https=) |
| ES (1) | ES2333358T3 (https=) |
| MX (1) | MX2007010484A (https=) |
| WO (1) | WO2006109301A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101160323A (zh) | 2005-04-15 | 2008-04-09 | 拉帕波特家族医学科学研究所 | 用于治疗mcp-1/ccr2相关疾病的分子及其使用方法 |
| CA2644594A1 (en) * | 2006-03-01 | 2007-09-07 | The Regents Of The University Of Michigan | Diagnosis and treatment of prostate cancer |
| CN103223165B (zh) | 2007-08-24 | 2015-02-11 | 学校法人庆应义塾 | 肿瘤细胞所导致的免疫抑制的解除剂及使用该解除剂的抗肿瘤剂 |
| CN102370981B (zh) * | 2010-08-11 | 2014-07-16 | 中国科学院上海生命科学研究院 | 防治神经退行性疾病的试剂和方法 |
| JPWO2015020040A1 (ja) * | 2013-08-06 | 2017-03-02 | 国立大学法人九州大学 | 有機酸重合体を有効成分とする癌細胞の生着予防又は生着抑制のための医薬 |
| NO2776305T3 (https=) * | 2014-04-23 | 2018-01-27 | ||
| CN107362353A (zh) * | 2016-05-11 | 2017-11-21 | 上海长海医院 | 一种去势抵抗的前列腺癌相关的药物靶点及其应用 |
| KR102308102B1 (ko) * | 2018-05-18 | 2021-10-07 | 가톨릭대학교 산학협력단 | Ccr2를 유효성분으로 포함하는 골질환의 예방 또는 치료용 조성물 |
| KR102308099B1 (ko) * | 2019-11-15 | 2021-10-01 | 가톨릭대학교 산학협력단 | Soluble CCR2 발현 유도된 줄기세포를 유효성분으로 포함하는 골질환의 예방 또는 치료용 조성물 |
| US12527842B2 (en) * | 2019-11-15 | 2026-01-20 | The Catholic University Of Korea Industry-Academic Cooperation Foundation | Composition for preventing or treating bone diseases comprising CCR2 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6132987A (en) * | 1994-01-13 | 2000-10-17 | The Regents Of The University Of California | Recombinant mammalian monocyte chemotactic protein-1 (MCP-1) receptors (MCP-1R, CCR-2) |
| SE9600820D0 (sv) * | 1996-03-01 | 1996-03-01 | Pharmacia Ab | Antibodies and their use |
| US6528625B1 (en) * | 1996-10-28 | 2003-03-04 | Millennium Pharmaceuticals, Inc. | Anti-CCR5 antibodies and kits comprising same |
| EP1263791A4 (en) * | 2000-02-09 | 2004-07-07 | Human Genome Sciences Inc | HUMAN G-PROTEIN CHEMOKIN RECEPTOR HDGNR10 (CCR5 RECEPTOR) |
| FR2828102B1 (fr) * | 2001-03-28 | 2004-07-09 | Ifc Sa | Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes |
| KR100453877B1 (ko) * | 2001-07-26 | 2004-10-20 | 메덱스젠 주식회사 | 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체 |
| DE602004006871T2 (de) | 2003-07-24 | 2008-02-07 | Amgen Inc., Thousand Oaks | Zusammensetzungen und verfahren, die multimere und oligomere lösliche fragmente des tweak-rezeptors betreffen |
| IL157398A0 (en) | 2003-08-14 | 2004-02-19 | Hadasit Med Res Service | Pharmaceutical compositions comprising ccr5 antagonists |
| WO2005058234A2 (en) | 2003-12-11 | 2005-06-30 | Yale University | Methods and compositions relating to ccr5 antagonist, ifn-ϝ and il-13 induced inflammation |
| US20050215543A1 (en) | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
| CN101160323A (zh) | 2005-04-15 | 2008-04-09 | 拉帕波特家族医学科学研究所 | 用于治疗mcp-1/ccr2相关疾病的分子及其使用方法 |
-
2006
- 2006-04-10 CN CNA2006800125405A patent/CN101160323A/zh active Pending
- 2006-04-10 WO PCT/IL2006/000454 patent/WO2006109301A2/en not_active Ceased
- 2006-04-10 MX MX2007010484A patent/MX2007010484A/es active IP Right Grant
- 2006-04-10 US US11/883,725 patent/US8388962B2/en not_active Expired - Fee Related
- 2006-04-10 EP EP06728255A patent/EP1871798B1/en not_active Expired - Lifetime
- 2006-04-10 CA CA002597789A patent/CA2597789A1/en not_active Abandoned
- 2006-04-10 DE DE602006009786T patent/DE602006009786D1/de not_active Expired - Lifetime
- 2006-04-10 AT AT06728255T patent/ATE445644T1/de not_active IP Right Cessation
- 2006-04-10 AU AU2006233927A patent/AU2006233927A1/en not_active Abandoned
- 2006-04-10 JP JP2008506051A patent/JP2008535909A/ja active Pending
- 2006-04-10 ES ES06728255T patent/ES2333358T3/es not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lutz | Polymerization of oligo (ethylene glycol)(meth) acrylates: Toward new generations of smart biocompatible materials | |
| JP2008535909A5 (https=) | ||
| Klok | Biological–synthetic hybrid block copolymers: combining the best from two worlds | |
| Thordarson et al. | Well-defined protein–polymer conjugates—synthesis and potential applications | |
| Lu et al. | N-trimethylsilyl amines for controlled ring-opening polymerization of amino acid N-carboxyanhydrides and facile end group functionalization of polypeptides | |
| WO2007001422A3 (en) | High affinity antibodies against hmgb1 and methods of use thereof | |
| JP2023103456A5 (https=) | ||
| WO2007084253A3 (en) | High affinity antibodies against hmgb1 and methods of use thereof | |
| JP2008538506A5 (https=) | ||
| Yang et al. | Synthesis and characterization of polyrotaxanes consisting of cationic α-cyclodextrins threaded on poly [(ethylene oxide)-ran-(propylene oxide)] as gene carriers | |
| Vandermeulen et al. | PEG-based hybrid block copolymers containing α-helical coiled coil peptide sequences: control of self-assembly and preliminary biological evaluation | |
| Krishna et al. | Synthesis of poly (propyl ether imine) dendrimers and evaluation of their cytotoxic properties | |
| JP2010532997A5 (https=) | ||
| Ten Brummelhuis et al. | Orthogonal multifunctionalization of random and alternating copolymers | |
| JP2012504965A5 (https=) | ||
| Klok et al. | Dendritic− graft polypeptides | |
| MX2007013031A (es) | Agentes terapeuticos de peptidos de toxina. | |
| JP2009527226A5 (https=) | ||
| JP2016521688A5 (https=) | ||
| JP2010503630A5 (https=) | ||
| JP2017500285A5 (https=) | ||
| JP2008509227A5 (https=) | ||
| Tzokova et al. | The effect of PEO length on the self-assembly of poly (ethylene oxide)− tetrapeptide conjugates prepared by “click” chemistry | |
| Scorciapino et al. | Antimicrobial peptidomimetics: reinterpreting nature to deliver innovative therapeutics | |
| JP2018535972A5 (https=) |